ArticleFrontiers in oncology2026

Atezolizumab-bevacizumab rechallenge after immune checkpoint inhibitor-associated myocarditis in advanced hepatocellular carcinoma: a case report.

Myriam Ayari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.